Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Emily A Vertosick

Showing results (21-30 of 89) with videos related to

Pageof 9
Sort By:
The Journal of Urology|May 21, 2020
Reply by AuthorsEmily A Vertosick, Christel Häggström, Daniel D Sjoberg, et al.
Clinical Trials (London, England)|July 5, 2023
A randomized comparison of two-stage versus traditional one-stage consent for a low-stakes randomized trialAndrew J Vickers, Emily A Vertosick, Mia Austria, et al.
Urology|July 18, 2021
Prospective Phase II Study to Evaluate Response to Two Induction Courses (12 intravesical instillations) of BCG Therapy for High-risk Non-muscle-invasive Bladder CancerHarry Herr, Emily A Vertosick, Guido Dalbagni, et al.
European Urology|September 22, 2018
Are We Improving Erectile Function Recovery After Radical Prostatectomy? Analysis of Patients Treated over the Last DecadePaolo Capogrosso, Emily A Vertosick, Nicole E Benfante, et al.
The Canadian Journal of Urology|August 24, 2017
Preoperative symptoms predict continence after post-radiation transurethral resection of prostateAllison Polland, Emily A Vertosick, Daniel D Sjoberg, et al.
BMC Urology|March 2, 2016
Global expression of AMACR transcripts predicts risk for prostate cancer - a systematic comparison of AMACR protein and mRNA expression in cancerous and noncancerous prostateSaeid Alinezhad, Riina-Minna Väänänen, Natalia Tong Ochoa, et al.
Urology Practice|August 28, 2024
Targeted Ablation Using Ultrasound-Guided Irreversible Electroporation of Index Tumors (TARGET Study): Prospective Development Study Evaluating Safety, Patient-Reported Outcomes, and Oncologic EfficacyJonathan Fainberg, Taehyoung Lee, Emily A Vertosick, et al.
Urologic Oncology|November 17, 2023
A brief mind-body intervention to reduce pain and anxiety during prostate needle biopsy: a clinically integrated randomized controlled trial with 2-staged consentChristopher D Gaffney, Emily A Vertosick, Sigrid V Carlsson, et al.
International Journal of Radiation Oncology, Biology, Physics|September 28, 2023
Evaluating a Physician Audit and Feedback Intervention to Increase Clinical Trial Enrollment in Radiation Oncology in a Multisite Tertiary Cancer Center: A Randomized StudyNicholas P Verdini, Daphna Y Gelblum, Emily A Vertosick, et al.
Clinical Chemistry|November 26, 2013
Genetic variation in KLK2 and KLK3 is associated with concentrations of hK2 and PSA in serum and seminal plasma in young menCharlotta Sävblom, Christer Halldén, Angel M Cronin, et al.
Pageof 9

Showing results (21-30 of 89) with videos related to

Sort By:
Pageof 9
The Journal of Urology|May 21, 2020
Reply by AuthorsEmily A Vertosick, Christel Häggström, Daniel D Sjoberg, et al.
Clinical Trials (London, England)|July 5, 2023
A randomized comparison of two-stage versus traditional one-stage consent for a low-stakes randomized trialAndrew J Vickers, Emily A Vertosick, Mia Austria, et al.
Urology|July 18, 2021
Prospective Phase II Study to Evaluate Response to Two Induction Courses (12 intravesical instillations) of BCG Therapy for High-risk Non-muscle-invasive Bladder CancerHarry Herr, Emily A Vertosick, Guido Dalbagni, et al.
European Urology|September 22, 2018
Are We Improving Erectile Function Recovery After Radical Prostatectomy? Analysis of Patients Treated over the Last DecadePaolo Capogrosso, Emily A Vertosick, Nicole E Benfante, et al.
The Canadian Journal of Urology|August 24, 2017
Preoperative symptoms predict continence after post-radiation transurethral resection of prostateAllison Polland, Emily A Vertosick, Daniel D Sjoberg, et al.
BMC Urology|March 2, 2016
Global expression of AMACR transcripts predicts risk for prostate cancer - a systematic comparison of AMACR protein and mRNA expression in cancerous and noncancerous prostateSaeid Alinezhad, Riina-Minna Väänänen, Natalia Tong Ochoa, et al.
Urology Practice|August 28, 2024
Targeted Ablation Using Ultrasound-Guided Irreversible Electroporation of Index Tumors (TARGET Study): Prospective Development Study Evaluating Safety, Patient-Reported Outcomes, and Oncologic EfficacyJonathan Fainberg, Taehyoung Lee, Emily A Vertosick, et al.
Urologic Oncology|November 17, 2023
A brief mind-body intervention to reduce pain and anxiety during prostate needle biopsy: a clinically integrated randomized controlled trial with 2-staged consentChristopher D Gaffney, Emily A Vertosick, Sigrid V Carlsson, et al.
International Journal of Radiation Oncology, Biology, Physics|September 28, 2023
Evaluating a Physician Audit and Feedback Intervention to Increase Clinical Trial Enrollment in Radiation Oncology in a Multisite Tertiary Cancer Center: A Randomized StudyNicholas P Verdini, Daphna Y Gelblum, Emily A Vertosick, et al.
Clinical Chemistry|November 26, 2013
Genetic variation in KLK2 and KLK3 is associated with concentrations of hK2 and PSA in serum and seminal plasma in young menCharlotta Sävblom, Christer Halldén, Angel M Cronin, et al.
Pageof 9